Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Gephion Bio ApS
APS
Active
Advertising protection
CVR 42358444
Fruebjergvej 3, 2100
København Ø
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2021 · 5 years old
4 employees
www.meattomorrow.com
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Gephion Bio ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
DV
David Valbjørn Christensen
Management
Management
2023
MH
Matias Heide Ankjær
Management
Management
2021
Former (1)
JC
Josef Christensen
Management
Management
2023 – 2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
KS
Katharine Sarah Holland
Board of Directors
Board of Directors
2024
DV
David Valbjørn Christensen
Board of Directors
Board of Directors
2024
MS
Mikkel Skorkjær Kongsfelt
Chairman
Chairman
2024
Shareholders
As of last annual report
Wallbear Invest ApS — 25–33.32%
Stem Cell ApS — 25–33.32%
Kempf ApS — 5–9.99%
Accelerace Invest II K/S — 5–9.99%
Niklis Holdings ApS — 5–9.99%
David Valbjørn Christensen — 33.33–49.99%
JChristensen Invest ApS — 10–14.99%
MATIAS ANKJÆR INVEST Aps — 33.33–49.99%
100%
Shareholder
Type
Ownership
Votes
Since
Wallbear Invest ApS
Company
25–33.32%
25–33.32%
2024
Stem Cell ApS
Company
25–33.32%
25–33.32%
2024
Kempf ApS
Company
5–9.99%
5–9.99%
2024
Accelerace Invest II K/S
Company
5–9.99%
5–9.99%
2025
Niklis Holdings ApS
Company
5–9.99%
5–9.99%
2024
David Valbjørn Christensen
Individual
33.33–49.99%
33.33–49.99%
2024
JChristensen Invest ApS
Company
10–14.99%
10–14.99%
2022
MATIAS ANKJÆR INVEST Aps
Company
33.33–49.99%
33.33–49.99%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Gephion Bio ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network